Deutsche Bank raised the firm’s price target on Option Care Health (OPCH) to $36 from $31 and keeps a Buy rating on the shares. The firm upped the price target after analyzing the impact of Stelara in 2026.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health: Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
- Option Care Health management to meet with Truist
- Option Care Health price target lowered to $27 from $30 at TD Cowen
- Option Care Health’s Earnings Call Highlights Growth and Challenges
- Option Care Health price target lowered to $36 from $38 at Citizens JMP